Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus

Parasites and Vectors

Volumn 9, Issue 1, 2016, Pages

  Botto, Carlos ^a   Basañez, María Gloria ^c   Escalona, Marisela ^a   Villamizar, Néstor J ^a   Noya Alarcón, Oscar ^a,b   Cortez, José ^a   Vivas Martínez, Sarai ^d   Coronel, Pablo ^a   Frontado, Hortencia ^a   Flores, Jorge ^e   Graterol, Beatriz ^f   Camacho, Oneida ^a   Tovar, Yseliam ^a   Borges, Daniel ^a   Morales, Alba Lucia ^g   Ríos, Dalila ^g   Guerra, Francisco ^e   Margeli, Héctor ^g   Rodriguez, Mario Alberto ^h   Unnasch, Thomas R ⁱ   Grillet, María Eugenia ^d   more..

^a Ministerio del Poder Popular para la Salud   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^e Inst Geografico de Venezuela S   (Venezuela)

^f INSTITUTO NACIONAL DE INVESTIGACIONES AGRÍCOLAS INIA   (Venezuela)

^g Onchocerciasis Elimination Program for the Americas   (Guatemala)

^h INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

ⁱ UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Amazonas; Ivermectin; Onchocerciasis; Simulium guianense sensu lato; Suppression; Transmission; Venezuela; Yanomami

Indexed keywords

AGE DISTRIBUTION; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; DISEASE SEVERITY; EYE INFECTION; HUMAN; INFECTION PREVENTION; MICROFILARIASIS; MORBIDITY; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE TRANSMISSION; POLYMERASE CHAIN REACTION; SEASONAL VARIATION; SEROLOGY; SEROPREVALENCE; SIMULIUM; SIMULIUM GUIANENSE; SKIN INFECTION; VENEZUELA; ANIMAL; FEMALE; GENETICS; GEOGRAPHY; INFANT; INSECT VECTOR; MALE; MICROFILARIA (NEMATODE LARVA); PARASITOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PREVALENCE; SEASON; SIMULIIDAE; TRANSMISSION;

INSECTICIDE; IVERMECTIN;

ANIMALS; CHILD, PRESCHOOL; FEMALE; GEOGRAPHY; HUMANS; INFANT; INSECT VECTORS; INSECTICIDES; IVERMECTIN; MALE; MICROFILARIAE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PREVALENCE; SEASONS; SIMULIIDAE; VENEZUELA;

EID: 84956915013     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-016-1313-z     Document Type: Article

References (58)

1. Duke BOL. Human onchocerciasis: an overview of the disease. Acta Leiden. 1990;59(1-2):9-24.
2. Bradley JE, Whitworth J, Basáñez MG. Onchocerciasis. In: Wakelin D, Cox F, Despommier D, Gillespie S, editors. Topley and Wilson's Microbiology and Microbial Infections (Parasitology). 10th ed. London: Edward Arnold Publishers; 2005. p. 781-801.
3. Robles R. Enfermedad nueva en Guatemala. Juv Med Guatemala. 1917;17:97-115.
4. World Health Organization. Elimination of onchocerciasis in the WHO Region of the Americas: Ecuador's progress towards verification of elimination. Wkly Epidemiol Rec. 2014;89(37):401-5.
5. Convit J, Schuler H, Borges R, Olivero V, Domínguez-Vázquez A, Frontado H, et al. Interruption of Onchocerca volvulus transmission in Northern Venezuela. Parasit Vectors. 2013;6(1):289.
6. Botto C, Villamizar N, Jokić Ž, Noya-Alarcón O, Cortéz J, Escalona M, et al. Landscape epidemiology of human onchocerciasis in Southern Venezuela. In: Reference Module in Earth Systems and Environmental Sciences. Elsevier; 2013. p. 1-14; doi: 10.1016/B978-0-12-409548-9.01790-5.
7. Vivas-Martínez S, Grillet ME, Botto C, Basáñez MG. Human onchocerciasis in the Amazonian focus. Bol Malariol Salud Ambiental. 2007;47:15-46. In Spanish.
8. Yarzábal L, Botto C, Arango M, Raga LM, Wong F, Allan R, et al. Epidemiological aspects of onchocerciasis in the Sierra Parima, Federal Territory of Amazonas, Venezuela. In: Yarzábal L, Botto C, Allan R, editors. La Oncocercosis en América. Caracas: PROICET Amazonas Publ. Cient. No. 3; 1985. p. 43-63.
9. Takaoka H, Suzuki H, Noda S, Tada I, Basáñez MG, Yarzábal L. Development of Onchocerca volvulus larvae in Simulium pintoi in the Amazonas region of Venezuela. Am J Trop Med Hyg. 1984;33(3):414-9.
10. Basáñez MG, Yarzábal L, Takaoka H, Suzuki H, Noda S, Tada I. The vectorial role of several blackfly species (Diptera: Simuliidae) in relation to human onchocerciasis in the Sierra Parima and Upper Orinoco regions of Venezuela. Ann Trop Med Parasitol. 1988;82(6):597-611.
11. Grillet ME, Basáñez MG, Vivas-Martínez S, Villamizar N, Frontado H, Cortez J, et al. Human onchocerciasis in the Amazonian area of southern Venezuela: spatial and temporal variation in biting and parity rates of black fly (Diptera: Simuliidae) vectors. J Med Entomol. 2001;38(4):520-30.
12. Grillet ME, Villamizar NJ, Frontado HL, Cortez J, Escalona M, Cortez J, et al. Vector competence of Simulium oyapockense s.l. and S. incrustatum for Onchocerca volvulus: implications for ivermectin-based control in the Amazonian focus of human onchocerciasis, a multi-vector-host system. Acta Trop. 2008;107(2):80-9.
13. Blanks J, Richards F, Beltrán F, Collins R, Alvarez E, Zea Flores G, et al. The Onchocerciasis Elimination Program for the Americas: a history of partnership. Rev Panam Salud Publica. 1998;3(6):367-74.
14. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol. 2008;102 Suppl 1:25-9.
15. Basáñez MG, Pion SDS, Boakes E, Filipe JAN, Churcher TS, Boussinesq M. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8(5):310-22.
16. Duke BOL, Zea-Flores G, Castro J, Cupp EW, Munoz B. Comparison of the effects of a single dose and four six-monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg. 1991;45:132-7.
17. Cupp EW, Duke BOL, Mackenzie CD, Guzmán JR, Vieira JC, Mendez-Galvan J, et al. The effects of long-term community-level treatment with ivermectin (Mectizan) on Onchocerca volvulus in Latin America. Am J Trop Med Hyg. 2004;71(5):602-7.
18. Rodríguez-Pérez MA, Lutzow-Steiner MA, Segura-Cabrera A, Lizarazo-Ortega C, Domínguez-Vázquez A, Sauerbrey M, et al. Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan. Am J Trop Med Hyg. 2008;79(2):239-44.
19. Duke BOL, Zea-Flores G, Castro J, Cupp EW, Munoz B. Effects of three-month doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg. 1992;46(2):189-94.
20. Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue, Duke BOL. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet. 2002;360(9328):203-10.
21. World Health Organization. Certification of elimination of human onchocerciasis: criteria and procedures. Geneva: World Health Organization; 2001. Available: http://whqlibdoc.who.int/hq/2001/WHO-CDS-CPE-CEE-2001.18b.pdf (accessed 3 November 2015).
22. Vivas-Martinez S, Basáñez MG, Grillet ME, Weiss H, Botto C, García M, et al. Onchocerciasis in the Amazonian focus of southern Venezuela: altitude and blackfly species composition as predictors of endemicity to select communities for ivermectin control programmes. Trans R Soc Trop Med Hyg. 1998;92(6):613-20.
23. Filipe JAN, Boussinesq M, Renz A, Collins RC, Vivas-Martinez S, Grillet ME, et al. Human infection patterns and heterogeneous exposure in river blindness. Proc Natl Acad Sci U S A. 2005;102(42):15265-70.
24. Onchocerciasis Elimination Program for the Americas. Evaluaciones Epidemiológicas de la Oncocercosis en América. Taller Operativo de Epidemiología. Ecuador: OEPA; 1996.
25. Carabin H, Escalona M, Marshall C, Vivas-Martínez S, Botto C, Joseph L, et al. Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach. Bull World Health Organ. 2003;81(7):482-90.
26. Vivas-Martínez S, Basáñez MG, Botto C, Rojas S, García M, Pacheco M, et al. Amazonian onchocerciasis: parasitological profiles by host-age, sex, and endemicity in southern Venezuela. Parasitology. 2000;121(5):513-25.
27. Winthrop KL, Proaño R, Oliva O, Arana B, Mendoza C, Dominguez A, et al. The reliability of anterior segment lesions as indicators of onchocercal eye disease in Guatemala. Am J Trop Med Hyg. 2006;75:1058-62.
28. Remme J, Ba O, Dadzie KY, Karam M. A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta river basin area. Bull World Health Organ. 1986;64(5):667-81.
29. Walsh JF, Davies JB, Le Berre R. Standardization of criteria for assessing the effect of Simulium control in the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg. 1978;72(6):675-6.
30. Grillet ME, Villamizar NJ, Cortez J, Frontado HL, Escalona M, Vivas-Martinez S, et al. Diurnal biting periodicity of parous Simulium (Diptera: Simuliidae) vectors in the onchocerciasis Amazonian focus. Acta Trop. 2005;94(2):139-58.
31. Katholi CR, Toé L, Merriweather A, Unnasch TR. Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. J Infect Dis. 1995;172(5):1414-7.
32. Rodríguez-Pérez MA, Lilley BG, Domínguez-Vázquez A, Segura-Arenas R, Lizarazo-Ortega C, Mendoza-Herrera A, et al. Polymerase chain reaction monitoring of transmission of Onchocerca volvulus in two endemic states in Mexico. Am J Trop Med Hyg. 2004;70(1):38-45.
33. Lovato R, Guevara A, Guderian R, Proaño R, Unnasch T, Criollo H, et al. Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution. PLoS Negl Trop Dis. 2014;8(5):e2821.
34. Program Coordinating Committee and OEPA staff. Guide to detecting a potential recrudescence of onchocerciasis during the post-treatment surveillance period: the American paradigm. Res Rep Trop Med. 2012;3:21-33. Available: http://www.oepa.net/Documentos/GuiaVEPT/Guide-Detection-Potential-Recrudescence During-PTS-Englishversion.pdf (accessed 3 November 2015).
35. Lobos E, Weiss N, Karam M, Taylor HR, Ottesen EA, Nutman TB. An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science. 1991;251(5001):1603-5.
36. Lipner EM, Dembele N, Souleymane S, Alley WS, Prevots DR, Toe L, et al. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J Infect Dis. 2006;194(2):216-21.
37. Gonzalez RJ, Cruz-Ortiz N, Rizzo N, Richards J, Zea-Flores G, Domínguez A, et al. Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala. PLoS Negl Trop Dis. 2009;3(3):e404.
38. Rodríguez-Pérez MA, Domínguez-Vázquez A, Unnasch TR, Hassan HK, Arredondo-Jiménez JI, Orozco-Algarra ME, et al. Interruption of transmission of Onchocerca volvulus in the Southern Chiapas Focus, México. PLoS Negl Trop Dis. 2013;7(3):e2133.
39. Basáñez MG, Churcher TS, Grillet ME. Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv Parasitol. 2009;68:263-313.
40. Basáñez MG, Collins RC, Porter CH, Little MP, Brandling-Bennett D. Transmission intensity and the patterns of Onchocerca volvulus infection in human communities. Am J Trop Med Hyg. 2002;67(6):669-79.
41. Lamberton PH, Cheke RA, Osei-Atweneboana MY, Winskill P, Shew KJ, Wilson MD, et al. Host choice by onchocerciasis vectors and ongoing transmission in areas under ivermectin control. Am J Trop Med Hyg. 2012;87(5 suppl):143.
42. Basáñez MG, Razali K, Renz A, Kelly D. Density-dependent host choice by disease vectors: epidemiological implications of the ideal free distribution. Trans R Soc Trop Med Hyg. 2007;101(3):256-69.
43. Turner HC, Walker M, Churcher TS, Osei-Atweneboana MY, Biritwum NK, Hopkins A, et al. Reaching the London Declaration on Neglected Tropical Diseases for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin Inf Dis. 2004;59(7):923-32.
44. World Health Organization/African Programme for Onchocerciasis Control. Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment. Available: http://www.who.int/apoc/oncho-elimination-report-english.pdf. Accessed 3 November 2015.
45. Stolk WA, Walker M, Coffeng LE, Basáñez MG, de Vlas SJ. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasit Vectors. 2015;8(1):552.
46. Davies JB. Description of a computer model of forest onchocerciasis transmission and its application to field scenarios of vector control and chemotherapy. Ann Trop Med Parasitol. 1993;87(1):41-63.
47. Chagnon NA. In: Spindler G, Spindler L, editors. Yanomami. Case studies in cultural anthropology. 5th ed. Fort Worth: Harcourt Brace College Publishers; 1997.
48. Taylor MJ, Hoerauf A, Townson S, Slatko BE, Ward SA. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis. Parasitology. 2014;141(1):119-27.
49. World Health Organization. Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico. Wkly Epidemiol Rec. 2015;90(43):577-81.
50. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, Doumbia K, et al. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis. 2012;6(9):e1825.
51. Katabarwa MN, Walsh F, Habomugisha P, Lakwo TL, Agunyo S, Oguttu DW, et al. Transmission of onchocerciasis in Wadelai focus of northwestern Uganda has been interrupted and the disease eliminated. J Parasitol Res. 2012;2012:748540.
52. Higazi TB, Zarroug IM, Mohamed HA, Elmubark WA, Deran TC, Aziz N, et al. Interruption of Onchocerca volvulus transmission in the Abu Hamed focus, Sudan. Am J Trop Med Hyg. 2013;89(1):51-7.
53. Katabarwa M, Lakwo T, Habomugisha P, Agunyo S, Byamukama E, Oguttu D, et al. Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted. Am J Trop Med Hyg. 2014;90(6):1159-66.
54. Katabarwa M, Richards F. Twice-yearly ivermectin for onchocerciasis: the time is now. Lancet Infect Dis. 2014;14(5):373-4.
55. Wanji S, Kengne-Ouafo JA, Esum ME, Chounna PW, Tendongfor N, Adzemye BF, et al. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment. Parasit Vectors. 2015;8:202.
56. West S, Munoz B, Sommer A. River blindness eliminated in Colombia. Ophthalmic Epidemiol. 2013;20(5):258-9.
57. Rodríguez-Pérez MA, Fernández-Santos NA, Orozco-Algarra ME, Rodríguez-Atanacio JA, Domínguez-Vázquez A, Rodríguez-Morales KB, et al. Elimination of onchocerciasis from Mexico. PLoS Negl Trop Dis. 2015;9(7):e0003922.
58. Richards F Jr, Rizzo N, Diaz Espinoza CE, Morales Monroy Z, Crovella Valdez CG, de Cabrera RM, et al. One hundred years after its discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus transmission has been eliminated from the central endemic zone. Am J Trop Med Hyg. 2015: 15-0364. [Epub ahead of print].